Find 44 companies with promising cash flow potential yet trading below their fair value.
To own Insperity, you need to believe its combination of high touch HR services and modern platforms like HR360, HRCore and HRScale can deepen relationships with small and mid sized clients while improving profitability. The SHRM26 showcase reinforces the near term catalyst around broader HRScale adoption, but it does not fundamentally change the central risk that healthcare and benefits costs and SMB hiring trends could keep margins under pressure.
The most relevant recent announcement is the February 2026 general availability of Insperity HRScale, built with Workday HCM capabilities. That launch set expectations that HRScale could open a larger mid market opportunity; the June SHRM26 presence now puts those capabilities in front of a dense audience of HR decision makers, which could influence how quickly HRScale and the wider suite contribute to revenue mix and operating leverage.
Yet investors should be aware that rising medical claims and benefits costs could still undermine the value of these new HR offerings if...
Read the full narrative on Insperity (it's free!)
Insperity's narrative projects $8.0 billion revenue and $94.5 million earnings by 2029.
Uncover how Insperity's forecasts yield a $40.50 fair value, a 6% upside to its current price.
By contrast, the most pessimistic analysts were modeling only about US$8.2 billion of revenue and roughly US$95.6 million of earnings by 2028, so you should weigh whether HRScale’s success at SHRM26 could challenge that cautious view or reinforce concerns about slower adoption and muted margin recovery.
Explore 4 other fair value estimates on Insperity - why the stock might be worth over 5x more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com